About Ten63
Ten63 is a company based in Durham (United States) founded in 2019 by Marcel Frenkel.. Ten63 has raised $18.3 million across 4 funding rounds from investors including ARE, Hatteras Venture Partners and Morpheus Ventures. The company has 18 employees as of December 31, 2024. Ten63 operates in a competitive market with competitors including Relay Therapeutics, Atomwise, Genesis Therapeutics, Unnatural Products and neoX Biotech, among others.
- Headquarter Durham, United States
- Employees 18 as on 31 Dec, 2024
- Founders Marcel Frenkel
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ten63 Therapeutics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$18.3 M (USD)
in 4 rounds
-
Latest Funding Round
-
Investors
ARE
& 15 more
-
Employee Count
18
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Ten63
Ten63 has successfully raised a total of $18.3M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Last Round
-
First Round
First Round
(01 Jun 2019)
- Investors Count 16
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2026 | Amount | Series A - Ten63 | Valuation |
investors |
|
| May, 2023 | Amount | Series A - Ten63 | Valuation | Hatteras Venture Partners | |
| Jan, 2021 | Amount | Seed - Ten63 | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Ten63
Ten63 has secured backing from 16 investors, including venture fund and institutional investors. Prominent investors backing the company include ARE, Hatteras Venture Partners and Morpheus Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech & Life Sciences focused VC firm investing in early stage companies in the US & Europe
|
Founded Year | Domain | Location | |
|
Early-stage technology investments are managed by Morpheus Ventures.
|
Founded Year | Domain | Location | |
|
Venture capital and accelerator services are provided across multiple sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ten63
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Ten63
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ten63 Comparisons
Competitors of Ten63
Ten63 operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Relay Therapeutics, Atomwise, Genesis Therapeutics, Unnatural Products and neoX Biotech, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Drug discovery platform is developed to study protein motion.
|
|
| domain | founded_year | HQ Location |
AI-driven platform for structure-based drug discovery is provided.
|
|
| domain | founded_year | HQ Location |
Computational platform for AI-driven small molecule drug discovery is developed.
|
|
| domain | founded_year | HQ Location |
Peptides are engineered via computational biology for undruggable targets.
|
|
| domain | founded_year | HQ Location |
Protein-protein interactions are researched and characterized to aid drug discovery.
|
|
| domain | founded_year | HQ Location |
An AI-driven degrader platform for drug discovery is developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Ten63
When was Ten63 founded?
Ten63 was founded in 2019.
Where is Ten63 located?
Ten63 is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Who is the current CEO of Ten63?
Marcel Frenkel is the current CEO of Ten63. They have also founded this company.
Is Ten63 a funded company?
Ten63 is a funded company, having raised a total of $18.3M across 4 funding rounds to date. The company's 1st funding round was a Seed of $2.15M, raised on Jun 01, 2019.
How many employees does Ten63 have?
As of Dec 31, 2024, the latest employee count at Ten63 is 18.
What does Ten63 do?
Ten63 was founded in 2019 and is based in Durham, United States, within the biotechnology sector. Therapeutics targeting undruggable proteins are developed through the companys COPPER platform, which employs proprietary AI technology alongside physical models. Protein chemical space is explored, and large datasets of molecules are screened to identify potential binding sites for drug candidates.
Who are the top competitors of Ten63?
Ten63's top competitors include Atomwise, Genesis Therapeutics and Unnatural Products.
Who are Ten63's investors?
Ten63 has 16 investors. Key investors include ARE, Hatteras Venture Partners, Morpheus Ventures, SOSV, and Draper Associates.